Eval CR 200 mg (Tablet (Controlled Release))
Unit Price: ৳ 5.00 (3 x 10: ৳ 150.00)
Strip Price: ৳ 50.00
Medicine Details
Category | Details |
---|---|
Generic | Sodium valproate |
Company | Unimed unihealth pharmaceuticals ltd |
Also available as |
Indications
- Treatment of all types of epilepsy
- Treatment of bipolar disorder
- Prophylaxis of migraine
Composition
- Sodium Valproate tablet: Each enteric-coated tablet contains Sodium Valproate BP 200 mg
- Sodium Valproate syrup: Each 5 ml syrup contains Sodium Valproate BP 200 mg
- Sodium Valproate controlled release 200 tablet: Each enteric-coated controlled release tablet contains Sodium Valproate 200 mg as Sodium Valproate BP 133.2 mg & Valproic acid BP 58 mg
- Sodium Valproate controlled release 300 tablet: Each enteric-coated controlled release tablet contains Sodium Valproate 300 mg as Sodium Valproate BP 199.8 mg & Valproic acid BP 87 mg
- Sodium Valproate controlled release 500 tablet: Each enteric-coated controlled release tablet contains Sodium Valproate 500 mg as Sodium Valproate BP 333 mg & Valproic acid BP 145 mg
- Sodium Valproate injection: Each 5 ml injectable solution contains Sodium Valproate BP eqv. to Valproic Acid 500 mg
Pharmacology
Anti-epileptic activity against a variety of seizures
Dosage & Administration
- Oral:
- May be given once or twice daily
- May be given in divided doses
- Epilepsy:
- Adult: Initial dose is 600 mg daily, increasing to a maximum of 2.5 g daily in divided doses
- Children (over 20 kg): Initially 400 mg daily, increased until control
- Children (up to 20 kg): Initially 20 mg/kg daily
- Bipolar disorder:
- Initially 600 mg daily
- Maintenance dosage is 1000-2000 mg daily
- Prophylaxis of migraine: 400-600 mg daily, some may require 1000-1500 mg daily
- Injection:
- Adults: Usually 400-800 mg depending on body weight, followed by continuous or repeated infusion
- Children: Initial: 20-30 mg/kg/day, Maximum: 40 mg/kg/day
Interaction
Acts as a non-specific inhibitor of drug metabolism
Contraindications
- Known hypersensitivity
- Liver dysfunction
- Restricted during pregnancy and in women of childbearing potential
Side Effects
- Common:
- Anorexia
- Nausea
- Vomiting
- CNS:
- Sedation
- Ataxia
- Tremor
- Hepatic function:
- Elevation of liver enzymes in plasma
- Fulminate hepatitis
- Acute pancreatitis
- Hyperammonemia
Pregnancy & Lactation
- Pregnancy: Associated with neural tube defects
- Lactation: Excreted in breast milk
Precautions & Warnings
- Liver function monitoring
- No undue potential for bleeding
- Care in renal impairment
- Avoid sudden withdrawal of therapy
Therapeutic Class
Primary anti-epileptic drugs
Storage Conditions
Do not store above 30°C, Keep away from light and out of the reach of children
Related Brands
- Proval 200 mg (Tablet) - general-pharmaceuticals-ltd
- Eval 250 mg (Tablet) - unimed-unihealth-pharmaceuticals-ltd
- Eval 250 mg/5 ml (Syrup) - unimed-unihealth-pharmaceuticals-ltd
- Valoate CR 500 mg (Tablet (Controlled Release)) - square-pharmaceuticals-plc
- Valoate CR 300 mg (Tablet (Controlled Release)) - square-pharmaceuticals-plc